Determinants of Cell-to-Cell Variability in Protein Kinase Signaling

por Jeschke, Matthias, Baumgärtner, Stephan, Legewie, Stefan
Publicado 2013

Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Syste...

por Jeschke, Matthias, Ludwig, Johannes M., Leyh, Catherine, Pabst, Kim M., Weber, Manuel, Theysohn, Jens M., Lange, Christian M., Herrmann, Ken, Schmidt, Hartmut H. -J., Jochheim, Leonie S.
Publicado 2023

Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World Analysis

por Leyh, Catherine, Ehmer, Ursula, Roessler, Daniel, Philipp, Alexander B., Reiter, Florian P., Jeliazkova, Petia, Jochheim, Leonie S., Jeschke, Matthias, Hammig, Janina, Ludwig, Johannes M., Theysohn, Jens M., Geier, Andreas, Lange, Christian M.
Publicado 2022

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

por de Castro, Tiago, Jochheim, Leonie S., Bathon, Melanie, Welland, Sabrina, Scheiner, Bernhard, Shmanko, Kateryna, Roessler, Daniel, Ben Khaled, Najib, Jeschke, Matthias, Ludwig, Johannes M., Marquardt, Jens U., Weinmann, Arndt, Pinter, Matthias, Lange, Christian M., Vogel, Arndt, Saborowski, Anna
Publicado 2022